87 related articles for article (PubMed ID: 2408060)
1. CD9 is an unreliable antibody for bone marrow purging.
Fort JA; Rios AM; Gross S; Janssen WE
Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF
Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140
[TBL] [Abstract][Full Text] [Related]
3. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
[TBL] [Abstract][Full Text] [Related]
4. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
[TBL] [Abstract][Full Text] [Related]
5. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging.
Janssen WE; Lee C; Gross S; Gee AP
Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
8. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
10. Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma.
Rhodes EG; Baker P; Rhodes JM; Davies JM; Cawley JC
Exp Hematol; 1991 Sep; 19(8):833-7. PubMed ID: 1714405
[TBL] [Abstract][Full Text] [Related]
11. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
13. [ICO-35 monoclonal antibodies to the antigen of acute lymphoblastic leukemia].
Baryshnikov AIu; Tupitsyn NN; Korotkova OV; Kadagidze ZG; Dostot E; Shmidt M; Boumsell L
Eksp Onkol; 1989; 11(5):52-3. PubMed ID: 2529115
[TBL] [Abstract][Full Text] [Related]
14. CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin.
Masellis-Smith A; Shaw AR
J Immunol; 1994 Mar; 152(6):2768-77. PubMed ID: 7511626
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal antibody and purging].
Ueda R; Morishima Y
Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
[No Abstract] [Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
Bai Y; Piao XH; Luo QL; Mao BZ
Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
19. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
20. Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia.
Vervoordeldonk SF; van den Berg H; von dem Borne AE; van Leeuwen EF; Slaper-Cortenbach IC
J Hematother; 1997 Oct; 6(5):495-500. PubMed ID: 9368186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
